Comparative Pharmacology
Head-to-head clinical analysis: HYDRO RIDE versus NATURETIN 2 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDRO RIDE versus NATURETIN 2 5.
HYDRO-RIDE vs NATURETIN-2.5
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Thiazide diuretic that inhibits sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium and water.
Bendroflumethiazide is a thiazide diuretic that inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption and promoting diuresis.
Initiate at 12.5-25 mg orally once daily. Titrate to 50-100 mg once daily. Maximum 200 mg per day.
Hypertension: 2.5 mg orally once daily; may increase to 5 mg daily if needed. Edema: 2.5 to 10 mg orally once daily.
None Documented
None Documented
Terminal half-life 4-6 hours (prolonged in renal impairment).
Terminal elimination half-life: 6-9 hours; prolonged in renal impairment and in elderly patients.
Primarily renal (50% unchanged; remainder as glucuronide conjugate); biliary/fecal <10%.
Renal excretion: approximately 95% as unchanged drug; biliary/fecal: <5%.
Category C
Category C
Thiazide Diuretic
Thiazide Diuretic